Correlation Between Mydecine Innovations and Mountain High

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Mountain High at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Mountain High into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mydecine Innovations Group and Mountain High Acquisitions, you can compare the effects of market volatilities on Mydecine Innovations and Mountain High and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Mountain High. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Mountain High.

Diversification Opportunities for Mydecine Innovations and Mountain High

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Mydecine and Mountain is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Mountain High Acquisitions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mountain High Acquis and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Mountain High. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mountain High Acquis has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Mountain High go up and down completely randomly.

Pair Corralation between Mydecine Innovations and Mountain High

If you would invest  0.80  in Mydecine Innovations Group on September 20, 2024 and sell it today you would lose (0.40) from holding Mydecine Innovations Group or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.59%
ValuesDaily Returns

Mydecine Innovations Group  vs.  Mountain High Acquisitions

 Performance 
       Timeline  
Mydecine Innovations 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.
Mountain High Acquis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mountain High Acquisitions has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, Mountain High is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Mydecine Innovations and Mountain High Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mydecine Innovations and Mountain High

The main advantage of trading using opposite Mydecine Innovations and Mountain High positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Mountain High can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mountain High will offset losses from the drop in Mountain High's long position.
The idea behind Mydecine Innovations Group and Mountain High Acquisitions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.